Zenicor Medical Systems AB
Zenicor Medical Systems AB (publ), a medical technology company, provides products and solutions for the diagnosis of arrhythmia and stroke prevention. The company offers Zenicor One, a handheld ECG device for arrhythmia; Zenicor Flex, a device that provides ECG data and arrhythmia detection; and Zenicor View, a web-based system solution for all types of arrhythmia investigations. It also provide… Read more
Zenicor Medical Systems AB (ZENI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.087x
Based on the latest financial reports, Zenicor Medical Systems AB (ZENI) has a cash flow conversion efficiency ratio of -0.087x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-3.46 Million) by net assets (Skr39.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zenicor Medical Systems AB - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Zenicor Medical Systems AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zenicor Medical Systems AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zenicor Medical Systems AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MACQUARIE GRP
MU:4M4
|
N/A |
|
Diamcor Mining Inc
OTCQB:DMIFF
|
-0.005x |
|
Moab Minerals Ltd
AU:MOM
|
-0.105x |
|
Bentre Aquaproduct Import and Export JSC
VN:ABT
|
N/A |
|
CARLSBERG -B- - Dusseldorf Stock Exchang
DU:CBGB
|
N/A |
|
Capital Appreciation Ltd
JSE:CTA
|
0.111x |
|
AMERICAN FINCL GRP
BE:QFI
|
-0.020x |
|
Media Investment Optimization SL
MC:MIO
|
-0.196x |
Annual Cash Flow Conversion Efficiency for Zenicor Medical Systems AB (2020–2024)
The table below shows the annual cash flow conversion efficiency of Zenicor Medical Systems AB from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr28.48 Million | Skr-596.23K | -0.021x | +90.91% |
| 2023-12-31 | Skr30.57 Million | Skr-7.04 Million | -0.230x | -163.96% |
| 2022-12-31 | Skr16.30 Million | Skr5.87 Million | 0.360x | +160.69% |
| 2021-12-31 | Skr18.05 Million | Skr2.49 Million | 0.138x | -16.81% |
| 2020-12-31 | Skr17.42 Million | Skr2.89 Million | 0.166x | -- |